======= FAM172A ======= == Gene Information == * **Official Symbol**: FAM172A * **Official Name**: family with sequence similarity 172 member A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83989|83989]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WUF8|Q8WUF8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FAM172A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FAM172A|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Arb2| |chromatin silencing by small RNA| |siRNA binding| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |regulation of alternative mRNA splicing, via spliceosome| |chromatin organization involved in regulation of transcription| |neural crest cell development| |negative regulation of gene expression, epigenetic| |stem cell development| |mesenchymal cell development| |gene silencing by RNA| |neural crest cell differentiation| |regulation of mRNA splicing, via spliceosome| |regulation of RNA splicing| |regulation of mRNA processing| |gene silencing| |mesenchymal cell differentiation| |stem cell differentiation| |mesenchyme development| |regulation of gene expression, epigenetic| |regulation of mRNA metabolic process| |RNA splicing| |mRNA processing| |mRNA metabolic process| |chromatin organization| |RNA processing| |endoplasmic reticulum| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |cell development| |RNA metabolic process| |negative regulation of gene expression| |tissue development| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-2.21| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|-2.04| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|-1.96| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|-1.85| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.81| |[[:results:exp332|Adefovir 20μM R07 exp332]]|-1.76| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.74| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|-1.74| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-1.73| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|2.12| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18772 * **Expression level (log2 read counts)**: 3.02 {{:chemogenomics:nalm6 dist.png?nolink |}}